Contents: Deep Dive – R&D Disruption

RandD Disruption Cover
Cover

R&D Disruption

Click here

RandD Disruption Introduction
Introduction

Welcome from the Editor

Click here

crowdsourcing
The power of crowdsourced R&D

Drug development is still dogged by attrition, duplication and waste. Oxford University’s Chas Bountra thinks the answer lies in opening up discoveries to everyone

Click here

Artificial Intelligence Meets Human Intelligence to Collaborate on Addressing Brain Health
AI meets human intelligence to collaborate on addressing brain health

Innovative digital technologies are stepping in to help with early detection of neurological diseases

Click here

The pharma world at your fingertips
The pharma world at your fingertips

Daily News from pharmaphorum – insights and analysis on the big trends shaping healthcare and the pharmaceutical industry

Click here

AstraZeneca Joris Silon
AstraZeneca on expanding its diabetes research franchise

AstraZeneca is hoping to build a strong franchise focused on cardiovascular, renal, and metabolic (CVRM) diseases. The company’s Joris Silon tells us more

Click here

Binging social media litening
Bringing social media listening into R&D

After her daughter was diagnosed with a rare disease, Maria Picone used social media listening to find the best ways to manage the condition. Now her company TREND Community is bringing these insights to pharma

Click here

Delivering change through better rare disease communications
Delivering change through better rare disease communications

OPEN Health’s Richard Jones, Gemma Allen and Charlotte Richards discuss the fundamental foundations of communications and how pharma can enable better outcomes

Click here

Takeda Georgia Keresty
Breadth versus depth in R&D management

Takeda’s Georgia Keresty is one of the only chief operating officers for R&D in the industry. She tells us what it involves and why it has been important in the wake of the Shire acquisition

Click here

Podcast

Listen to discussions of key industry trends with leading pharma figures

Click here

Staying on the cutting edge of oncology advances
Staying on the cutting edge of oncology

Rapidly-changing treatment landscapes in diseases like lung cancer pose challenges for medical education providers, who need to be more adaptable than ever

Click here

An innovative approach to improving-research and patient care with NHS data
Improving research with NHS data

Understanding how patients are treated in routine clinical care has great potential to improve treatment and enrich academic research

Click here

RandD Disruption future editions
Forthcoming issues of Deep Dive

Sign up to receive complimentary editions of the magazine direct to your inbox, including the forthcoming Market Access: Breaking Barriers issue

Click here

RandD Disruption Contact
Deep Dive – contact us

How to get in touch with the magazine’s editorial, commercial and design teams

Click here

Video
Share

Your name

Your e-mail

Name receiver

E-mail address receiver

Your message

Send

Share

E-mail

Facebook

Twitter

LinkedIn

Contact

Send